Mitsubishi UFJ Morgan Stanley Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-70
Closed -$7K 63
2022
Q4
$7K Buy
70
+10
+17% +$965 0.06% 133
2022
Q3
$6K Hold
60
0.08% 129
2022
Q2
$6K Hold
60
0.01% 133
2022
Q1
$6K Sell
60
-150
-71% -$15.8K 0.01% 143
2021
Q4
$22K Buy
+210
New +$19.4K 0.01% 125
2014
Q4
$54K Hold
560
0.11% 47
2014
Q3
$45K Buy
560
+100
+22% +$7.88K 0.13% 62
2014
Q2
$35K Sell
460
-220
-32% -$16.6K 0.1% 73
2014
Q1
$51K Buy
680
+150
+28% +$10.6K 0.14% 49
2013
Q4
$38K Hold
530
0.06% 86
2013
Q3
$30K Buy
+530
New +$31.6K 0.05% 143

Other funds holding CVS

Mitsubishi UFJ Morgan Stanley Securities's CVS Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of CVS Health (CVS) in Q1 2023, closing a stake of 70 shares — an estimated $7K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in CVS in Q3 2013 and held it in 11 quarters. The position peaked at $54K in Q4 2014. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 70 CVS Health shares in Q1 2023, an estimated $7K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in CVS Health in Q3 2013 and held it in 11 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's CVS Health position peaked at $54K in Q4 2014.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.